↓ Skip to main content

Dove Medical Press

Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma

Overview of attention for article published in Biologics: Targets & Therapy, June 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (71st percentile)

Mentioned by

policy
1 policy source
patent
12 patents

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
7 Mendeley
Title
Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma
Published in
Biologics: Targets & Therapy, June 2010
DOI 10.2147/btt.s7818
Pubmed ID
Authors

Peter E Clark

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 57%
Professor 1 14%
Researcher 1 14%
Lecturer 1 14%
Readers by discipline Count As %
Medicine and Dentistry 5 71%
Computer Science 1 14%
Unknown 1 14%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 October 2023.
All research outputs
#5,570,518
of 25,806,080 outputs
Outputs from Biologics: Targets & Therapy
#73
of 286 outputs
Outputs of similar age
#22,810
of 106,153 outputs
Outputs of similar age from Biologics: Targets & Therapy
#1
of 4 outputs
Altmetric has tracked 25,806,080 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 286 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 106,153 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them